近日，由钉钉团队研发的深度研究系统"Dingtalk-DeepResearch"在国际权威评测中取得突破性成绩，在 DeepResearch Bench测试中以48.49分位列全球第二、国内第一，超越OpenAI、Claude等主流系统。 为应对企业场景的动态变化，该框架区别于传统静态架构，通过熵引导、记忆感知的在线学习机制使智 能体能够持续演进，就像员工可通过反复实践提升技能，而无需人工干预。该机制保障系统能自动从历 史交互中归纳经验，逐步适应不同企业的业务流程与用户操作风格。 例如，当用户多次修改AI输出的报告格式后，系统会自主学习并记忆用户对格式、风格及关键点的偏 好，在后续生成中主动对齐用户需求。在钉钉企业级AI平台中，这种经个性化调优的偏好可以作为一 种能力沉淀并共享给团队乃至整个公司，实现组织知识的复用与增效。 闭环评估与优化系统，保障企业级 AI输出质量 据悉，该系统已成功应用于制造业、供应链等复杂场景，能够在复杂异构表格、多阶段推理与多模态生 成任务中保持行业领先的准确性和稳健性，帮助企业高效处理多模态数据，实现智能升级。 钉钉深度研究系统的这项进展，首次实现了国际顶级基准与实际生产落地的双重 ...

智通财经APP获悉，近日，由钉钉团队研发的深度研究系统"Dingtalk-DeepResearch"在国际权威评测中取得突破性成绩，在DeepResearch Bench测试中以 48.49分位列全球第二、国内第一，超越OpenAI、Claude等主流系统。 30 Score 20 10 例如，当用户多次修改AI输出的报告格式后，系统会自主学习并记忆用户对格式、风格及关键点的偏好，在后续生成中主动对齐用户需求。在钉钉企业级 AI平台中，这种经个性化调优的偏好可以作为一种能力沉淀并共享给团队乃至整个公司，实现组织知识的复用与增效。 闭环评估与优化系统，保障企业级 AI 输出质量 钉钉深度研究系统的这项进展，首次实现了国际顶级基准与实际生产落地的双重突破，标志着中国企业级AI技术迈入国际第一梯队。 让多个AI系统像团队协作般解决复杂问题 Dingtalk-DeepResearch 的核心是设计了一种面向真实企业场景的多智能体深度研究框架，将深度研究生成、异构表格解析与推理、多模态报告生成有效整合 在同一系统中。 这一设计就像是将不同专业能力的团队成员整合到一个系统中：有的擅长分析表格数据，有的负责生成报告，有的协 ...

Buybacks and Increases - Jinzhai Food plans to repurchase shares worth between 50 million to 100 million yuan [1] - Everbright Bank sees CITIC Financial Assets increase its shareholding ratio to 1% [1] External Investments and Daily Operations - Shenzhen Energy intends to invest 7.897 billion yuan in the construction of the Shantou Honghai Bay offshore wind power project [2] - Qidi Design has won a bid for an 860 million yuan intelligent computing center project [2] - Beixin Road and Bridge has secured a bid for the G217 Aral to Tumxuk highway project, totaling 1.629 billion yuan [3] - Saiyi Information plans to increase investment in Douhao Technology to enhance enterprise-level AI technology connectivity [4] - Luxshare Precision intends to issue H-shares and list on the main board of the Hong Kong Stock Exchange [4] - Jinlong Co. plans to acquire approximately 29.32% of the shares of intelligent computing service company Shenzhen Benmao [5] - Titan Technology plans to use self-owned or raised funds of 5.7564 million pounds to acquire 100% of Apollo Scientific Ltd. from Central Glass Co., Ltd. [5] - East China Pharmaceutical's wholly-owned subsidiary HDM1002 has received FDA approval for clinical trials in the U.S. for weight management in overweight or obese populations [5] - Jiadu Technology plans to transfer 10% of its partnership interest in Anhui New Infrastructure Fund for 40 million yuan [6] - Zhongyuan Tong intends to jointly invest 10 million yuan with Zhengfang Technology to establish a joint venture [7] Performance Changes - Rongzhi Rixin expects a net profit of 14 million to 15 million yuan for the first half of the year, representing a year-on-year increase of 2027.62% to 2179.59%, driven by significant revenue growth in the wind power and petrochemical industries [8] - Weiguang Co. reports a net profit of 172 million yuan for the first half of the year, an increase of 11.32% year-on-year [9]